Latest Breaking News On - Ispy2 - Page 1 : comparemela.com

Denise M. Wolf, PhD, discusses the methods used to conduct the I-SPY2 study and the implications that immune biomarkers could have on selecting treatment for patients with hormone receptor–positive, HER2-negative breast cancer in the future.

San-francisco
California
United-states
Denisem-wolf
Michaelj-campbell
Department-of-laboratory-medicine
University-of-california
Laboratory-medicine
Cancer-cell
Investigational-device-exemption
Phd